96 related articles for article (PubMed ID: 3156579)
1. Lipopolysaccharide tolerance inhibits eye inflammation. II. Preliminary studies on the mechanism.
Howes EL; Rosenbaum JT
Arch Ophthalmol; 1985 Feb; 103(2):261-5. PubMed ID: 3156579
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects.
Howes EL; Goldyne ME; Perez HD; Goldstein IM; Rosenbaum JT
Arch Ophthalmol; 1985 Feb; 103(2):257-60. PubMed ID: 3156578
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin tolerance diminishes certain antiinflammatory effects of endotoxin.
Rosenbaum JT; Hartiala KT; Howes EL; Goldstein IM
Inflammation; 1985 Sep; 9(3):297-308. PubMed ID: 2931363
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment.
Verma MJ; Mukaida N; Vollmer-Conna U; Matsushima K; Lloyd A; Wakefield D
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2465-70. PubMed ID: 10509638
[TBL] [Abstract][Full Text] [Related]
5. Complement and polymorphonuclear leukocytes do not determine the vascular permeability induced by intraocular LPS.
Howes EL; Wong KL; Hartiala KT; Webster RO; Rosenbaum JT
Am J Pathol; 1985 Jan; 118(1):35-42. PubMed ID: 3155595
[TBL] [Abstract][Full Text] [Related]
6. Ocular inflammatory responses in the EP2 and EP4 receptor knockout mice.
Biswas S; Bhattacherjee P; Paterson CA; Tilley SL; Koller BH
Ocul Immunol Inflamm; 2006 Jun; 14(3):157-63. PubMed ID: 16766399
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist.
Rubin RM; Samples JR; Rosenbaum JT
Arch Ophthalmol; 1988 Aug; 106(8):1116-20. PubMed ID: 3261165
[TBL] [Abstract][Full Text] [Related]
8. Biphasic ocular inflammatory response to endotoxin-induced uveitis in the mouse.
Shen DF; Chang MA; Matteson DM; Buggage R; Kozhich AT; Chan CC
Arch Ophthalmol; 2000 Apr; 118(4):521-7. PubMed ID: 10766138
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of glucosamine on endotoxin-induced uveitis in Lewis rats.
Chang YH; Horng CT; Chen YH; Chen PL; Chen CL; Liang CM; Chien MW; Chen JT
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5441-9. PubMed ID: 18719082
[TBL] [Abstract][Full Text] [Related]
10. Effect of artesunate on endotoxin-induced uveitis in rats.
Wang XQ; Liu HL; Wang GB; Wu PF; Yan T; Xie J; Tang Y; Sun LK; Li C
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):916-9. PubMed ID: 20881305
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of hyperbaric oxygen for the treatment of experimental uveitis induced in rabbits.
Erşanli D; Karadayi K; Toyran S; Akin T; Sönmez M; Ciftçi F; Top C; Elbüken E
Ocul Immunol Inflamm; 2005; 13(5):383-8. PubMed ID: 16419423
[TBL] [Abstract][Full Text] [Related]
12. The effects of naringin and naringenin on endotoxin-induced uveitis in rats.
Shiratori K; Ohgami K; Ilieva I; Jin XH; Yoshida K; Kase S; Ohno S
J Ocul Pharmacol Ther; 2005 Aug; 21(4):298-304. PubMed ID: 16117693
[TBL] [Abstract][Full Text] [Related]
13. High-dose infliximab prophylaxis in endotoxin-induced uveitis.
Diaz-Llopis M; García-Delpech S; Salom D; Udaondo P; Bosch-Morell F; Quijada A; Romero FJ; Amselem L
J Ocul Pharmacol Ther; 2007 Aug; 23(4):343-50. PubMed ID: 17803432
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis.
Allen JB; McGahan MC; Ferrell JB; Adler KB; Fleisher LN
Exp Eye Res; 1996 Jan; 62(1):21-8. PubMed ID: 8674509
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis.
Mashimo H; Ohguro N; Nomura S; Hashida N; Nakai K; Tano Y
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5450-7. PubMed ID: 18757518
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis.
Ohgami K; Ilieva I; Shiratori K; Koyama Y; Jin XH; Yoshida K; Kase S; Kitaichi N; Suzuki Y; Tanaka T; Ohno S
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):275-81. PubMed ID: 15623784
[TBL] [Abstract][Full Text] [Related]
17. Effect of transforming growth factor beta-1 in endotoxin-induced uveitis.
Peng B; Li Q; Roberge FG; Chan CC
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):257-60. PubMed ID: 9008650
[TBL] [Abstract][Full Text] [Related]
18. Modification of lipid A reduces endotoxin-induced eye effects.
Rosenbaum JT; Langlois L; Enkel H; Wolfrom JA
Curr Eye Res; 1985 Jun; 4(6):707-11. PubMed ID: 3896656
[TBL] [Abstract][Full Text] [Related]
19. Activity of an interleukin 1 receptor antagonist in rabbit models of uveitis.
Rosenbaum JT; Boney RS
Arch Ophthalmol; 1992 Apr; 110(4):547-9. PubMed ID: 1532889
[TBL] [Abstract][Full Text] [Related]
20. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
